How many patents does
Institute For Research In Biomedicine have?
patents
573
families
39
granted
130
applications
443
US
111
EP
58
WO
51
CN
34
JP
33
KR
17
GB
1
RoW
268
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Institute For Research In Biomedicine
Top ten assignees appearing on patents
2009 - 2018
| regeneron pharmaceuticals | 110 |
| humabs | 37 |
| inst res in biomedicine | 5 |
| inst research in biomedicine | 4 |
| humab | 4 |
| humabs biomed | 3 |
| humabs llc (us) | 2 |
| regeneron pharma | 2 |
2018
| regeneron pharmaceuticals | 22 |
| humabs biomed | 2 |
| humabs | 1 |
Institute For Research In Biomedicine
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| human cytomegalovirus neutralizing antibodies and use thereof | 126 | 2008 |
| human cytomegalovirus neutralising antibodies and use thereof | 61 | 2007 |
| neutralizing anti-influenza a virus antibodies and uses thereof | 44 | 2008 |
| humanized m-csf mice | 41 | 2011 |
| genetically modified non-human animals and methods of use thereof | 31 | 2012 |
| genetically modified mice and engraftment | 29 | 2009 |
| methods for producing antibodies from plasma cells | 26 | 2008 |
| genetically modified non-human animals and methods of use thereof | 24 | 2012 |
| monoclonal antibody production by ebv transformation of b cells | 24 | 2003 |
| human cytomegalovirus neutralising antibodies and use thereof | 22 | 2008 |